<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2985088R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4967</journal-id>
<journal-id journal-id-type="nlm-ta">J Mol Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Mol. Biol.</journal-id>
<journal-title-group>
<journal-title>Journal of molecular biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-2836</issn>
<issn pub-type="epub">1089-8638</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28450074</article-id>
<article-id pub-id-type="pmc">5492995</article-id>
<article-id pub-id-type="doi">10.1016/j.jmb.2017.04.009</article-id>
<article-id pub-id-type="manuscript">NIHMS871363</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Structural basis of MeCP2 distribution on non-CpG methylated and hydroxymethylated DNA</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sperlazza</surname>
<given-names>M. Jeannette</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<!--<email>jetsperlazza@unc.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bilinovich</surname>
<given-names>Stephanie M.</given-names>
</name>
<xref ref-type="aff" rid="A1">b</xref>
<!--<email>smb42@email.unc.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sinanan</surname>
<given-names>Leander M.</given-names>
</name>
<xref ref-type="aff" rid="A1">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Javier</surname>
<given-names>Fatima R.</given-names>
</name>
<xref ref-type="aff" rid="A2">d</xref>
<!--<email>fatimaraezelle.javier@case.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>David C.</given-names>
<suffix>Jr.</suffix>
</name>
<xref ref-type="aff" rid="A1">e</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
<!--<email>david_willjr@med.unc.edu</email>-->
</contrib>
</contrib-group>
<aff id="A1"><label>a,b,c,e</label>Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA</aff>
<aff id="A2"><label>d</label>Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106, USA</aff>
<author-notes>
<corresp id="FN1"><label>#</label>corresponding author: +1-919-843-9949 (phone), +1-919-966-6718 (fax), Campus Box #7525, Brinkhous-Bullitt Building, Chapel Hill NC 27599-7525, United States</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>19</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>429</volume>
<issue>10</issue>
<fpage>1581</fpage>
<lpage>1594</lpage>
<!--elocation-id from pubmed: 10.1016/j.jmb.2017.04.009-->
<abstract id="Abs1">
<p id="P2">The Rett syndrome-associated methyl-CpG binding protein 2 (MeCP2) selectively binds methylated DNA to regulate transcription during the development of mature neurons. Like other members of the methyl-CpG binding domain (MBD) family, MeCP2 functions through the recognition of symmetrical 5-methylcytosines in CpG (mCG) dinucleotides. Advances in base level resolution epigenetic mapping techniques have revealed, however, that MeCP2 can bind asymmetrically methylated and hydroxymethylated CpA (h/mCA) dinucleotides and this alternative binding selectivity modifies gene expression in the developing mammalian brain. The structural determinants of binding to mCA and hydroxymethylated DNA have not been previously investigated. Here, we employ ITC and NMR spectroscopy to characterize MeCP2 binding to methylated and hydroxymethylated mCG and mCA DNA; examine the effects of Rett syndrome-associated missense mutations; and make comparisons to the related and evolutionarily most ancient protein, MBD2. These analyses reveal that MeCP2 binds mCA with high affinity in a strand-specific and orientation-dependent manner. In contrast, MBD2 does not show high affinity or methyl-specific binding to mCA. The Rett-associated missense mutations (T158M, R106W, and P101S) destabilize the MeCP2 MBD and disrupt recognition of mCG and mCA equally. Finally, hydroxymethylation of a high-affinity mCA site does not alter the binding properties; whereas, hemi-hydroxylation of the equivalent cytosine in an mCG site decreases affinity and specificity. Based on these findings, we suggest MeCP2 recognition of methylated/hydroxymethylated CpA dinucleotides functions as an epigenetic switch redistributing MeCP2 among mCG and mCA loci.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical Abstract</title>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms871363u1.jpg"></graphic></p>
</abstract>
<kwd-group>
<kwd>epigenetics</kwd>
<kwd>Rett syndrome</kwd>
<kwd>methyl-binding domain</kwd>
<kwd>protein-DNA interaction</kwd>
<kwd>relaxation dispersion</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>